|
LAMP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.863100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.843970E-02 |
| Normal-vs-Stage2 |
1.754790E-01 |
| Normal-vs-Stage3 |
6.615800E-02 |
| Normal-vs-Stage4 |
3.913700E-02 |
| Stage1-vs-Stage2 |
9.157200E-01 |
| Stage1-vs-Stage3 |
9.865800E-01 |
| Stage1-vs-Stage4 |
7.159000E-01 |
| Stage2-vs-Stage3 |
9.210800E-01 |
| Stage2-vs-Stage4 |
7.099200E-01 |
| Stage3-vs-Stage4 |
7.447600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.460100E-02 |
| Normal-vs-AfricanAmerican |
1.877170E-03 |
| Normal-vs-Asian |
2.498200E-02 |
| Caucasian-vs-AfricanAmerican |
6.155900E-03 |
| Caucasian-vs-Asian |
2.078600E-01 |
| AfricanAmerican-vs-Asian |
1.746580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.277400E-01 |
| Normal-vs-Female |
2.139100E-03 |
| Male-vs-Female |
1.335660E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.870080E-02 |
| Normal-vs-Age(41-60Yrs) |
4.595500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.639800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.475800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.251000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.342000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.354030E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.369400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.346200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.860210E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.758000E-01 |
| Classical-VS-Follicular |
7.715600E-02 |
| Classical-VS-Other |
2.109000E-01 |
| Classical-VS-Normal |
1.876630E-03 |
| Tall-VS-Follicular |
2.768000E-02 |
| Tall-VS-Other |
7.717900E-02 |
| Tall-VS-Normal |
1.740960E-03 |
| Follicular-VS-Other |
6.695400E-01 |
| Follicular-VS-Normal |
5.643000E-01 |
| Other-VS-Normal |
7.134600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.292440E-01 |
| Normal-vs-N1 |
2.465200E-01 |
| N0-vs-N1 |
8.188600E-01 |
|
|
